From FMT to Next-Generation Microbiome Therapeutics
Faecal microbiota transplantation (FMT) has demonstrated the potential of using intestinal microbial communities to treat disease, particularly recurrent Clostridioides difficile infection (CDI). Its success has helped establish a growing field of microbiome-based therapeutics, with researchers exploring new approaches to delivering, characterising and standardising microbial treatments.From oral capsules to defined bacterial communities and engineered microorganisms, these […]